These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24296878)

  • 1. Hepatic stellate cells promote tumor progression by enhancement of immunosuppressive cells in an orthotopic liver tumor mouse model.
    Zhao W; Zhang L; Xu Y; Zhang Z; Ren G; Tang K; Kuang P; Zhao B; Yin Z; Wang X
    Lab Invest; 2014 Feb; 94(2):182-91. PubMed ID: 24296878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice.
    Zhao W; Zhang L; Yin Z; Su W; Ren G; Zhou C; You J; Fan J; Wang X
    Int J Cancer; 2011 Dec; 129(11):2651-61. PubMed ID: 21213212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated hepatic stellate cells regulate MDSC migration through the SDF-1/CXCR4 axis in an orthotopic mouse model of hepatocellular carcinoma.
    Xu Y; Fang F; Jiao H; Zheng X; Huang L; Yi X; Zhao W
    Cancer Immunol Immunother; 2019 Dec; 68(12):1959-1969. PubMed ID: 31641797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma.
    Liu M; Zhou J; Liu X; Feng Y; Yang W; Wu F; Cheung OK; Sun H; Zeng X; Tang W; Mok MTS; Wong J; Yeung PC; Lai PBS; Chen Z; Jin H; Chen J; Chan SL; Chan AWH; To KF; Sung JJY; Chen M; Cheng AS
    Gut; 2020 Feb; 69(2):365-379. PubMed ID: 31076403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2.
    Xu Y; Zhao W; Xu J; Li J; Hong Z; Yin Z; Wang X
    Oncotarget; 2016 Feb; 7(8):8866-78. PubMed ID: 26758420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic Stellate Cells Enhance Liver Cancer Progression by Inducing Myeloid-Derived Suppressor Cells through Interleukin-6 Signaling.
    Hsieh CC; Hung CH; Chiang M; Tsai YC; He JT
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of hepatic stellate cells in the regulation of T-cell function and the promotion of hepatocellular carcinoma.
    Zhao W; Su W; Kuang P; Zhang L; Liu J; Yin Z; Wang X
    Int J Oncol; 2012 Aug; 41(2):457-64. PubMed ID: 22641338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic modulators of hepatic stellate cells for hepatocellular carcinoma.
    Ruan Q; Wang H; Burke LJ; Bridle KR; Li X; Zhao CX; Crawford DHG; Roberts MS; Liang X
    Int J Cancer; 2020 Sep; 147(6):1519-1527. PubMed ID: 32010970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell apoptosis induced by intratumoral activated hepatic stellate cells is associated with lung metastasis in hepatocellular carcinoma.
    Xia YH; Wang ZM; Chen RX; Ye SL; Sun RX; Xue Q; Huang Y
    Oncol Rep; 2013 Sep; 30(3):1175-84. PubMed ID: 23807027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bear bile inhibits the immunosuppression activity of hepatic stellate cells in vivo.
    Zhou CS; Yin ZY; Zhao WX; Zhang L; You JY; Su WX; Fan J; Wang XM
    Hepatogastroenterology; 2012; 59(117):1529-36. PubMed ID: 22683969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence imaging sheds light on the immune evasion mechanisms of hepatic stellate cells mediated by superoxide anion.
    Mao Y; Wu C; Wang X; Zhang F; Qi X; Li X; Li P; Tang B
    Commun Biol; 2024 May; 7(1):558. PubMed ID: 38730013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous Tumor Cell Lysate-Loaded Dendritic Cell Vaccine Inhibited Tumor Progression in an Orthotopic Murine Model for Hepatocellular Carcinoma.
    Wang Q; Luan W; Warren L; Kadri H; Kim KW; Goz V; Blank S; Isabel Fiel M; Hiotis SP
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):574-582. PubMed ID: 26786094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18β-glycyrrhetinic acid inhibits hepatocellular carcinoma development by reversing hepatic stellate cell-mediated immunosuppression in mice.
    Kuang P; Zhao W; Su W; Zhang Z; Zhang L; Liu J; Ren G; Yin Z; Wang X
    Int J Cancer; 2013 Apr; 132(8):1831-41. PubMed ID: 22991231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
    Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF
    J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined anti-hepatocellular carcinoma therapy inhibit drug-resistance and metastasis via targeting "substance P-hepatic stellate cells-hepatocellular carcinoma" axis.
    Li Z; Wang F; Li Y; Wang X; Lu Q; Wang D; Qi C; Li C; Li Z; Lian B; Tian G; Gao Z; Zhang B; Wu J
    Biomaterials; 2021 Sep; 276():121003. PubMed ID: 34273686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor immune response of folate-conjugated chitosan nanoparticles containing the IP-10 gene in mice with hepatocellular carcinoma.
    Lai C; Yu X; Zhuo H; Zhou N; Xie Y; He J; Peng Y; Xie X; Luo G; Zhou S; Zhao Y; Lu X
    J Biomed Nanotechnol; 2014 Dec; 10(12):3576-89. PubMed ID: 26000371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinase inhibitor Sorafenib modulates immunosuppressive cell populations in a murine liver cancer model.
    Cao M; Xu Y; Youn JI; Cabrera R; Zhang X; Gabrilovich D; Nelson DR; Liu C
    Lab Invest; 2011 Apr; 91(4):598-608. PubMed ID: 21321535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin.
    Song J; Ge Z; Yang X; Luo Q; Wang C; You H; Ge T; Deng Y; Lin H; Cui Y; Chu W; Yao M; Zhang Z; Gu J; Fan J; Qin W
    Cancer Lett; 2015 Jan; 356(2 Pt B):713-20. PubMed ID: 25449435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow mesenchymal stem cells suppress ascitogenous hepatoma progression in BALB/c mouse through reducing myeloid-derived suppressor cells.
    Su X; Zhang L; Ye J; Yang L; Li Y; Wang Y
    Biomed Mater Eng; 2015; 25(1 Suppl):167-77. PubMed ID: 25538067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma.
    Wang Z; He L; Li W; Xu C; Zhang J; Wang D; Dou K; Zhuang R; Jin B; Zhang W; Hao Q; Zhang K; Zhang W; Wang S; Gao Y; Gu J; Shang L; Tan Z; Su H; Zhang Y; Zhang C; Li M
    J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34489334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.